Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?

Randomized Trials ◽

Checkpoint Inhibitors ◽

Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation

Leukemia Research ◽

10.1016/j.leukres.2009.10.028 ◽

2010 ◽

Vol 34 (6) ◽

pp. 723-727 ◽

Cited By ~ 59

Author(s):

Z.Y. Lim ◽

V. Fiaccadori ◽

S. Gandhi ◽

J. Hayden ◽

M. Kenyon ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Haematopoietic Stem Cell Transplantation ◽

Haematopoietic Stem Cell ◽

Reduced Intensity Conditioning ◽

Reduced Intensity ◽

WT1expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes

10.1111/j.1365-2141.2009.08063.x ◽

2010 ◽

Vol 149 (3) ◽

pp. 451-454 ◽

Cited By ~ 16

Author(s):

Sara Galimberti ◽

Francesco Ghio ◽

Francesca Guerrini ◽

Elena Ciabatti ◽

Susanna Grassi ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Adult Patients ◽

Time To Progression ◽

Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia

10.1111/j.1365-2141.2004.04862.x ◽

2004 ◽

Vol 124 (6) ◽

pp. 843-844 ◽

Cited By ~ 18

Author(s):

M. F. Johan ◽

D. T. Bowen ◽

M. E. Frew ◽

A. C. Goodeve ◽

G. A. Wilson ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

ACUTE MYELOID LEUKAEMIA, MIXED PHENOTYPE ACUTE LEUKAEMIA, THE MYELODYSPLASTIC SYNDROMES AND HISTIOCYTIC NEOPLASMS

Bone Marrow Pathology ◽

10.1002/9781119398929.ch4 ◽

2019 ◽

pp. 185-266

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Acute Leukaemia ◽

Mixed Phenotype ◽

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients

10.1111/bjh.16680 ◽

2020 ◽

Vol 190 (3) ◽

pp. 461-464

Author(s):

Pierre Peterlin ◽

Thomas Cluzeau ◽

Maxime Jullien ◽

Anne‐Marie Ngo Nloga ◽

Anne Calleja ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia

10.1111/j.1365-2141.2005.05412.x ◽

2005 ◽

Vol 129 (1) ◽

pp. 60-65 ◽

Cited By ~ 52

Author(s):

M. F. Johan ◽

D. T. Bowen ◽

M. E. Frew ◽

A. C. Goodeve ◽

J. T. Reilly

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Aberrant Methylation ◽

Negative Regulators ◽

DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia

10.1111/j.1365-2141.2011.08879.x ◽

2011 ◽

Vol 156 (3) ◽

pp. 413-414 ◽

Cited By ~ 16

Author(s):

Norio Shiba ◽

Tomohiko Taki ◽

Myoung-ja Park ◽

Akira Shimada ◽

Manabu Sotomatsu ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial

The Lancet Haematology ◽

10.1016/s2352-3026(17)30228-4 ◽

2018 ◽

Vol 5 (1) ◽

pp. e34-e43 ◽

Cited By ~ 33

Author(s):

Moshe Mittelman ◽

Uwe Platzbecker ◽

Boris Afanasyev ◽

Sebastian Grosicki ◽

Raymond S M Wong ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Severe Thrombocytopenia ◽

Phase 2 ◽

Phase 2 Trial ◽

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Journal of Hematology & Oncology ◽

10.1186/s13045-016-0263-4 ◽

2016 ◽

Vol 9 (1) ◽

Cited By ~ 18

Author(s):

Lisa Pleyer ◽

Sonja Burgstaller ◽

Reinhard Stauder ◽

Michael Girschikofsky ◽

Heinz Sill ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

World Health Organization ◽

Myeloid Leukaemia ◽

World Health ◽

Front Line ◽

Health Organization ◽

French American British ◽

VERY-LOW-DOSE CYTARABINE FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKAEMIA IN THE ELDERLY

The Lancet ◽

10.1016/s0140-6736(86)91061-5 ◽

1986 ◽

Vol 327 (8487) ◽

pp. 966 ◽

Cited By ~ 22

Author(s):

Alison Worsley ◽

G.J. Mufti ◽

J.A. Copplestone ◽

D.G. Oscier ◽

T.J. Hamblin

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Low Dose ◽

The Elderly ◽

Low Dose Cytarabine ◽